UNITY Biotechnology, Inc. UNBX
0.06
0.00
0.00%
as of 14 Oct
- Market cap
- $3.4M
- P/E
- 0.0×
Follow UNBX
Growth Flags
show if company had growth for consecutive years
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| (231.27%) | (148.97%) | (86.96%) | (87.32%) |
+8 more TTM periods Free account |
|
| (61.66%) | (50.29%) | (37.62%) | (39.08%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(231.91%) | (140.77%) | (84.55%) | (95.38%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.31) | (1.24) | (1.33) | (1.45) | |
Free Cash Flow |
(22.04) | (20.84) | (22.39) | (24.33) | |
Capital Expenditures |
— | 0.03 | 0.14 | 0.12 | |
| Other line items | |||||
Cash ROIC |
(131.75%) | (70.20%) | (52.19%) | (45.51%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.80 | 0.80 | 1.03 | 0.81 | |
Depreciation/Fixed assets |
0.90 | 0.82 | (0.01) | 1.21 | |
Capex/Depreciation |
0.00 | 0.01 | (2.98) | 0.02 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.31) | (1.24) | (1.34) | (1.45) | |
Capex per Share |
0.00 | 0.00 | 0.01 | 0.01 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates